HNRNPA2B1 and central nervous system cancer: It was also confirmed that HNRPA2/B1 overexpressed in glioma tissue specimens is associated with advanced glioma grade and knockdown of HNRPA2/B1 leads to reduced glioblastoma cell viability, adhesion, migration, invasion, as well as chemoresistance for TMZ.